Viewing Study NCT00215956


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-05-23 @ 10:02 AM
Study NCT ID: NCT00215956
Status: COMPLETED
Last Update Posted: 2013-12-23
First Post: 2005-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Topotecan View
None Rectal Neoplasms View
None Radiosensitizing View